![Philip Breitfeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Breitfeld
Directeur Général chez
The Breitfeld Group, LLC
Fortune : 56 216 $ au 31/07/2026
Profil
Philip Breitfeld is the founder of The Breitfeld Group, LLC, founded in 2016, serving as Managing Director since its founding.
Dr. Breitfeld is currently Chief Medical Officer at Allterum Therapeutics, Inc., a position held since 2020.
Former jobs include Independent Director at Champions Oncology, Inc. from 2016 to 2026, Vice President at IQVIA, Inc., Global Vice President at Quintiles, Inc. (California) from 2011 to 2015, and Associate Chief Medical Officer at BioCrystal Ltd. from 2007 to 2009.
Education includes a doctorate from Rochester Christian University and an undergraduate degree from Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CHAMPIONS ONCOLOGY, INC. 0,08 % | 05/11/2025 | 10 488 ( 0,08 % ) | 56 216 $ | 31/07/2026 |
Postes actifs de Philip Breitfeld
| Sociétés | Poste | Début |
|---|---|---|
Allterum Therapeutics, Inc.
 Allterum Therapeutics, Inc. BiotechnologyHealth Technology Develops lymphoblastic leukemia therapy | Directeur Technique/Scientifique/R&D | 01/12/2020 |
The Breitfeld Group, LLC
 The Breitfeld Group, LLC Real Estate Investment TrustsFinance Acts as a Real Estate Investment Trust/REIT | Directeur Général | 01/01/2016 |
Anciens postes connus de Philip Breitfeld
| Sociétés | Poste | Fin |
|---|---|---|
| CHAMPIONS ONCOLOGY, INC. | Directeur/Membre du Conseil | 24/03/2026 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Corporate Officer/Principal | 01/12/2015 |
BioCrystal Ltd.
 BioCrystal Ltd. Chemicals: SpecialtyProcess Industries Develops nano life sciences and clinical medicine | Corporate Officer/Principal | 01/01/2009 |
| IMS HEALTH, INC. | Corporate Officer/Principal | - |
Formation de Philip Breitfeld
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IQVIA, Inc.
 IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
BioCrystal Ltd.
BioCrystal Ltd. Chemicals: SpecialtyProcess Industries Develops nano life sciences and clinical medicine | Process Industries |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Champions Oncology, Inc.
 Champions Oncology, Inc. BiotechnologyHealth Technology Provides advanced technology solutions and services for oncology drugs | Health Technology |
Allterum Therapeutics, Inc.
Allterum Therapeutics, Inc. BiotechnologyHealth Technology Develops lymphoblastic leukemia therapy | Health Technology |
The Breitfeld Group, LLC
The Breitfeld Group, LLC Real Estate Investment TrustsFinance Acts as a Real Estate Investment Trust/REIT | Finance |
